Literature DB >> 11739065

Estrogen replacement therapy and antidepressant response to sertraline in older depressed women.

L S Schneider1, G W Small, C M Clary.   

Abstract

The influence of the use of estrogen replacement therapy (ERT) on the antidepressant response to sertraline of 127 women over 60 years old was evaluated with data from two multicenter trials. At endpoint, sertraline-treated women taking ERT had significantly greater global improvement and quality of life than those not receiving ERT. Modest improvements were also observed in anxiety symptoms and cognitive functioning. The results provide preliminary evidence that ERT use (without progesterone) in older depressed women may augment the antidepressant response to sertraline in terms of quality of life and general improvement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739065

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  28 in total

1.  Recognizing and Treating the Physical Symptoms of Depression in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

2.  An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.

Authors:  Jeremy Barowsky; Thomas L Schwartz
Journal:  Psychiatry (Edgmont)       Date:  2006-07

Review 3.  Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.

Authors:  Claudio N Soares
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

Review 4.  Hormone treatment of depression.

Authors:  Russell T Joffe
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

5.  The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women.

Authors:  Susan G Kornstein; Elizabeth A Young; Annie T Harvey; Stephen R Wisniewski; Jennifer L Barkin; Michael E Thase; Madhukar H Trivedi; Andrew A Nierenberg; A John Rush
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

6.  Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.

Authors:  Anita H Clayton; Philip T Ninan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 7.  Evaluation of the potential antidepressant effects of soybean isoflavones.

Authors:  Mark Messina; Carey Gleason
Journal:  Menopause       Date:  2016-12       Impact factor: 2.953

Review 8.  Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

Authors:  Claudio N Soares; Jennifer R Poitras; Jennifer Prouty
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Interaction between estrogens and antidepressants in the forced swimming test in rats.

Authors:  Erika Estrada-Camarena; Alonso Fernández-Guasti; Carolina López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  2004-01-17       Impact factor: 4.530

10.  Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.

Authors:  E Estrada-Camarena; N M Vega Rivera; C Berlanga; A Fernández-Guasti
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.